Use of adjuvant chemotherapy and outcomes in women age 70 and older with HER2-positive (HER2+) or triple-negative (TN) breast cancer (BC). This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...
New 48-week data from the Phase IIIb APEX trial (NCT04882098) show Tremfya (guselkumab; Johnson & Johnson) produces sustained inhibition of radiographic progression and improved clinical symptoms in ...
The National Childbirth Trust, the U.K.’s largest charity for parents, has revealed that 38 percent of new dads experience mental health issues following the birth of their child. The NCT study also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback